Speakers Bureau

Faculty willing to give educational talks in Boston and surrounding communities about prevention, brain health, warning signs for Alzheimer’s disease and opportunities for clinical trials.

Lenore Jackson-Pope, RN, BSN, MSM, CCRP

Co-Director of Primary Care Outreach
Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital
Massachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital

Lenore is the Co-Director of Primary Care Outreach at the Center for Alzheimer Research and Treatment and the Massachusetts Alzheimer’s Disease Research Center. She is instrumental in educating primary care physicians about the warning signs of Alzheimer’s disease and direct referral networks. Lenore is the former Manager of Research and Medical Education at the Massachusetts/New Hampshire Chapter of the Alzheimer’s Association, and has supported clinical research operations for over 30 years. She is an Adjunct Faculty Member at Emmanuel College in the Graduate and Professionals Management Program, and a registered nurse who has worked in both acute and long-term care settings. Lenore is passionate about the importance of clinical trial participation and is forever grateful to the many wonderful research volunteers she has been privileged to work with over the years.

Cynthia A. Lemere, Ph.D.

Scientist, Ann Romney Center for Neurologic Diseases, Brigham & Women's Hospital
Associate Professor of Neurology, Harvard Medical School

Dr. Lemere focuses on translational research for understanding, preventing and treating Alzheimer's disease. Dr. Lemere earned a bachelor’s degree in Psychology and Education from Mount Holyoke College and a master’s in Neurobiology from SUNY Albany. Dr. Lemere examined Alzheimer's-related brain changes in people with Down syndrome in the Selkoe Laboratory at Brigham and Women's Hospital while pursuing her doctorate in Pathology at Boston University School of Medicine. After receiving her Ph.D., she remained at the Center as a Postdoctoral Research Fellow, Instructor, Assistant Professor and is currently an Associate Professor in the Department of Neurology. Her current research involves: a) preclinical studies of antibody-treatments and vaccines, with and without focused ultrasound treatments, to reduce a disease-relevant form of the amyloid-beta protein that accumulates and forms plaques in the Alzheimer’s brain; b) the role of the body’s immune host-defense system (e.g., complement) in Alzheimer’s disease progression; and, c) the effects of deep space galactic cosmic radiation on brain aging and the risk of Alzheimer’s in preparation for NASA’s first manned mission to Mars in the 2030s. Dr. Lemere participates in local and national mentoring programs for underrepresented minorities including high school, undergraduate and medical students. Dr. Lemere serves on several national and international scientific advisory boards, including the National Alzheimer’s Association Medical and Scientific Advisory Council, the Dominantly Inherited Alzheimer’s Network Therapeutic Unit (DIAN-TU) Therapeutic Evaluation Committee, the International Alzheimer’s Disease/Parkinson’s Disease (ADPD) Conference Scientific Advisory Council, the BrightFocus Foundation Scientific Review Council and the DownSyndrome Achieves Biobank Governing Board of Directors. In addition, she serves as a scientific advisor for several companies

Gad A. Marshall. M.D.

Associate Medical Director of Clinical Trials, Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Massachusetts General Hospital
Assistant Professor of Neurology, Harvard Medical School

Gad Marshall is board certified in Neurology. He is currently the Associate Medical Director of Clinical Trials at the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital; Associate Neurologist at Brigham and Women’s Hospital; Assistant in Neurology at Massachusetts General Hospital; and Assistant Professor of Neurology at Harvard Medical School. Dr. Marshall has been site principal investigator for multiple clinical trials of amyloid-modifying drugs in Alzheimer’s disease and is currently the site principal investigator for the Alzheimer’s Disease Neuroimaging Initiative (ADNI) 3, DoD-ADNI, and the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) trial. His research has focused on clinical correlates of activities of daily living and neuropsychiatric symptoms with multiple imaging markers and cerebrospinal fluid biomarkers across the early Alzheimer’s disease spectrum, as well as developing novel, sensitive, and ecologically-valid assessments for early functional changes in Alzheimer's disease.

Scott McGinnis, M.D.

Assistant Professor of Neurology, Harvard Medical School

Scott McGinnis is a a behavioral neurologist at the BWH Center for Brain Mind Medicine, an investigator in the BWH Center for Alzheimer Research and Treatment and an investigator in the MGH Frontotemporal Disorders Unit. He completed his residency in neurology in the MGH/BWH program and a fellowship in behavioral neurology and neuropsychiatry at BWH. Dr. McGinnis’ career comprises patient care, education of students, residents, and fellows, and clinical research studies on aging and neurodegenerative dementias. His research interests include atypical presentations of Alzheimer disease and non-Alzheimer cognitive neurodegenerative disorders.

Alison J. McManus N.P.

Dr. McManus is board certified as a Family Nurse Practitioner and Principal Investigator within the Department of Neurology at Massachusetts General Hospital (MGH).  Dr. McManus graduated as a Registered Nurse in 1987 and subsequently became Certified in both Intensive Care and Emergency Nursing.  She received an MSN as a Family Nurse Practitioner from the University of San Diego and a Doctorate in Nursing Practice from Rush University in Chicago. 

Dr McManus is the Clinical Research Nurse Manager of the Alzheimer’s Clinical & Translational Research Unit (ACTRU) at MGH.  Her work broadly involves the management of translational and clinical trial activities at the ACTRU.   She supervises the conduct of sponsor and investigator-initiated trials, as well as the clinical care of patients enrolled in clinical research projects, within the ACTRU.  Dr McManus is one of only a handful of Nurse Practitioners in the nation who are leading these types of clinical drug trials as a Principal Investigator.

Kathryn V. Papp, Ph.D.

Neuropsychologist, Department of Neurology, Brigham and Women's Hospital 
Research Staff, Department of Neurology, Massachusetts General Hospital
Assistant Professor, Harvard Medical School

Kathryn Papp, PhD is a clinical neuropsychologist with a primary interest in the early detection of Alzheimer’s disease (AD) using sensitive semantic and associative memory tests as well as computerized measures and digital technologies to identify and track older adults at risk for cognitive decline. She is additionally interested in modifiable lifestyle factors which may mitigate cognitive decline in older adults.

Dorene M. Rentz, PsyD

Associate Professor of Neurology, Harvard Medical School
Departments of Neurology, Brigham and Women's Hospital, Massachusetts General Hospital

Dorene M. Rentz, PsyD, is an Associate Professor of Neurology at Harvard Medical School with dual appointments in the Departments of Neurology at Brigham and Women’s Hospital and Massachusetts General Hospital, Boston, Massachusetts. She completed her degree in clinical psychology/neuropsychology in 1987 and has worked as a clinical neuropsychologist for 30 years. She serves in multiple capacities as the Co-Director of the Center for Alzheimer Research and Treatment; the Director of Neuropsychology of the Massachusetts Alzheimer’s Disease Research Center (MADRC); Director of the Outreach, Recruitment and Education Core and Clinical Core Director of the Harvard Aging Brain Study. Her research interests include early detection of cognitive and behavioral changes in preclinical Alzheimer’s disease using novel cognitive assessments as well as amyloid and tau PET imaging. On an international level, Dorene is involved in designing cognitive outcome measures for secondary prevention trials in AD and is a proponent of validating at-home computerized assessments. 

Jeffrey M. Robbins, LICSW

Clinical Social Worker, Brigham and Women's Hospital, Teaching Associate, Harvard Medical School

Jeffrey Robbins is a licensed clinical social worker in Neurology at Brigham and Women’s Hospital and a Teaching Associate in Neurology at Harvard Medical School. Jeff has spent the last 35 years counseling individuals and families living with Alzheimer’s disease and he has given multiple presentations on issues pertaining to caregivers. In 1998 he co-founded The Eleanor Robbins Community Program: Caring for Each Other; a Volunteer program for students wanting to learn about Alzheimer’s disease through weekly visits with a nursing home resident on a dementia care unit. This program became the template for a non- profit, National Alzheimer’s Buddies (NAB), an initiative involving college students who visit those living with Alzheimer’s. NAB currently has 10 colleges across the country who are participating in this program.

Joel A. Salinas, M.D.

Instructor of Neurology at Harvard Medical School and Massachusetts General Hospital

Additional Languages Spoken: Spanish

Dr. Joel Salinas is an Instructor of Neurology at Harvard Medical School and Massachusetts General Hospital. After studying the intersection of biology and sociology at Cornell University, he completed his medical degree at the University of Miami Miller School of Medicine followed by neurology residency at the Massachusetts General Hospital and Brigham and Women’s Hospital. He subsequently completed a combined research and clinical fellowship in Behavioral Neurology and Neuropsychiatry at Massachusetts General Hospital. He conducts research in social and behavioral epidemiology to understand the complex neurobiological interplay between social relationships and brain health.

Qing-Mei Wang, M.D., Ph.D.

Director, Stroke Biological Recovery Laboratory, Spaulding Rehabilitation Hospital
Physician, Spaulding Rehabilitation Hospital, Massachusetts General Hospital
Assistant Professor, Harvard Medical School

Additional Languages Spoken: Mandarin

Dr. Qing Mei Wang obtained her B.S. at Fudan University in Shanghai (1991), Ph.D. (1998) and M.D. (2004) at the University of Medicine and Dentistry of New Jersey and completed residency training in Physical Medicine and Rehabilitation at Mount Sinai Medical Center in New York (2008). She is currently an assistant professor at Harvard Medical School, attending physician at Spaulding Rehabilitation Hospital (SRH), associate physician at Massachusetts General Hospital (MGH), and director of Stroke Biological Recovery Laboratory at Spaulding Rehabilitation Hospital. She provides inpatient/outpatient clinical care, supervises trainees, and conducts research on stroke recovery to enhance our knowledge and the quality of patient care. Dr. Wang’s research involves cellular, animal and clinical disciplines, aiming to bridge basic science breakthrough to bedside therapy, including genetic study, pharmacological intervention and non-invasive brain stimulation to promote stroke recovery. She is also active in community services reaching out to the Chinese population.

Pages